PCR food testing

NEP Singapore Moves into New Connected Production Facility

Retrieved on: 
Wednesday, June 7, 2023
Mobile, Wireless, Technology, Other Sports, General Sports, Communications, Entertainment, Media, General Entertainment, Electronic Commerce, Digital Marketing, Audio, Video, Content Marketing, Other Technology, Telecommunications, Software, Other Entertainment, TV and Radio, Internet, Online, Sports, Mobile Entertainment, Other Communications, Data Management, Consumer Electronics, Life, Multimedia, NEP Group, Engineering, NEP, Japan, PCR food testing, Network equipment provider, Renewable energy

NEP Singapore , part of the NEP Group worldwide network, today announced the opening of a new broadcast production facility in the northeast of Singapore, strengthening the company’s investment and presence in the region to meet the growing demand for connected broadcast production solutions in Southeast Asia and the Middle East.

Key Points: 
  • NEP Singapore , part of the NEP Group worldwide network, today announced the opening of a new broadcast production facility in the northeast of Singapore, strengthening the company’s investment and presence in the region to meet the growing demand for connected broadcast production solutions in Southeast Asia and the Middle East.
  • NEP Singapore is part of NEP Group’s Asia-Pacific connectivity expansion utilizing 10GB circuits between NEP Australia, NEP Japan, NEP Singapore and NEP U.S., giving each region dedicated connectivity via NEP Connect’s Anylive® fiber network, providing more opportunities for clients by increasing the utilization of resources and solutions across NEP Group’s global production ecosystem.
  • “We’re very proud to open the doors to our new NEP Singapore home where we’ll continue to offer our clients the very best broadcast production solutions,” says Saeed Izadi, President, NEP Singapore, India and Middle East.
  • Visit NEP Singapore and nepgroup.com to learn more about our global ecosystem of connected, broadcast and live events solutions.

Global Food Safety Testing Market Report 2022-2028: Industry to Surpass $32 Billion During Forecast Period - ResearchAndMarkets.com

Retrieved on: 
Monday, July 25, 2022
Food, Beverage, Retail, Virus, Contamination, Time, Food contaminant, Pesticide, Growth, US, COVID-19, Certification, Lists of countries and territories, Food safety, PCR food testing, Agriculture

The "Global Food Safety Testing Market (by Contaminants, Pathogens, Type of Food Tested, Technology/Method, Region), Impact of COVID-19, Company Profiles, Major Acquisitions and Recent Developments - Forecast to 2028" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Food Safety Testing Market (by Contaminants, Pathogens, Type of Food Tested, Technology/Method, Region), Impact of COVID-19, Company Profiles, Major Acquisitions and Recent Developments - Forecast to 2028" report has been added to ResearchAndMarkets.com's offering.
  • The global food safety testing market is predicted to surpass US$ 32 Billion by 2028.
  • Food contamination is quickly becoming a worldwide issue, that is raising the concern for adequate food safety testing methods and procedures.
  • Companies engaged in the manufacturing and distributions of food products are mandated by respective regional and international regulatory agencies to implement food safety testing and certification.

The Waning COVID-19 Pandemic's Lasting Effect on Point-Of-Care, Discussed by IDTechEx

Retrieved on: 
Tuesday, May 31, 2022
COVID-19 testing, Diabetes, Severe acute respiratory syndrome coronavirus 2, COVID-19, Laboratory, Emergency Use Authorization, Conditional sentence, Research, Point-of-care testing, Infection, EUA, Food, BD, PCR food testing, Government, United States Army, Players, Technology, Becton, FDA, Airport, Federal Food, Drug, and Cosmetic Act, Roche, Subscription business model, Consultant, Sale, Ageing, Degenerative disease, Population growth, Growth, Army of the United States, Abbott Laboratories, Dickinson, Pharmaceutical industry

BOSTON, May 31, 2022 /PRNewswire/ -- COVID-19 cases peaked in Europe and North America over January 2022 yet revenue from point-of-care testing did not all peak across the board. Some market leaders continued to see rapid growth in Q1 sales from this wintertime peak, and companies that launched their first diagnostic platform via COVID-19 testing continued to grow their platform install bases. Yet others began to feel the decline throughout Q1, indicating a waning pandemic. As COVID-19 cases fall from their wintertime peak, companies are moving to prepare for the following clinical need for flu/COVID-19 multiplexed testing before the onset of the next flu season. In the report "Biosensors for Point-of-Care Diagnostics 2022-2032: Technology, Opportunities, Players and Forecasts", IDTechEx investigates how the point-of-care market has been shaped by COVID-19. IDTechEx explores the emerging technologies that are enabling point-of-care, and what applications will drive the market beyond COVID-19.

Key Points: 
  • What is COVID-19's lasting effect on point-of-care testing?
  • In the report " Biosensors for Point-of-Care Diagnostics 2022-2032: Technology, Opportunities, Players and Forecasts ", IDTechEx investigates how the point-of-care market has been shaped by COVID-19.
  • IDTechEx explores the emerging technologies that are enabling point-of-care, and what applications will drive the market beyond COVID-19.
  • Consequently, IDTechEx expects the point-of-care industry to grow over the next ten years, with a forecast of $29.5 billion by 2032.

The Waning COVID-19 Pandemic's Lasting Effect on Point-Of-Care, Discussed by IDTechEx

Retrieved on: 
Tuesday, May 31, 2022
COVID-19 testing, Diabetes, Severe acute respiratory syndrome coronavirus 2, COVID-19, Laboratory, Emergency Use Authorization, Conditional sentence, Research, Point-of-care testing, Infection, EUA, Food, BD, PCR food testing, Government, United States Army, Players, Technology, Becton, FDA, Airport, Federal Food, Drug, and Cosmetic Act, Roche, Subscription business model, Consultant, Sale, Ageing, Degenerative disease, Population growth, Growth, Army of the United States, Abbott Laboratories, Dickinson, Pharmaceutical industry

BOSTON, May 31, 2022 /PRNewswire/ -- COVID-19 cases peaked in Europe and North America over January 2022 yet revenue from point-of-care testing did not all peak across the board. Some market leaders continued to see rapid growth in Q1 sales from this wintertime peak, and companies that launched their first diagnostic platform via COVID-19 testing continued to grow their platform install bases. Yet others began to feel the decline throughout Q1, indicating a waning pandemic. As COVID-19 cases fall from their wintertime peak, companies are moving to prepare for the following clinical need for flu/COVID-19 multiplexed testing before the onset of the next flu season. In the report "Biosensors for Point-of-Care Diagnostics 2022-2032: Technology, Opportunities, Players and Forecasts", IDTechEx investigates how the point-of-care market has been shaped by COVID-19. IDTechEx explores the emerging technologies that are enabling point-of-care, and what applications will drive the market beyond COVID-19.

Key Points: 
  • What is COVID-19's lasting effect on point-of-care testing?
  • In the report " Biosensors for Point-of-Care Diagnostics 2022-2032: Technology, Opportunities, Players and Forecasts ", IDTechEx investigates how the point-of-care market has been shaped by COVID-19.
  • IDTechEx explores the emerging technologies that are enabling point-of-care, and what applications will drive the market beyond COVID-19.
  • Consequently, IDTechEx expects the point-of-care industry to grow over the next ten years, with a forecast of $29.5 billion by 2032.